“…There were 32 types of TFBSs within the first intron fragment, including the enhancers, i.e., CCAAT/enhancer binding protein beta (CEBPB), CCAAT/enhancer binding protein alpha (CEBP), cAMP activated protein (CAP), GATA binding elements (GATA1), LIM-only protein 2 (LMO2COM), myeloid zinc finger 1 (MZF1), simian-virus-40-protein-1 (SP1), basic helix–loop–helix transcription factors (USF), the repressor, acute myeloid leukemia-1 (AML1), and the enhancers or repressor GRE [17,31]. There were also some elements with unclear functions, i.e., AP1, replication initiator 1 (AP4), AP1FJ, c-Ets-1 (CETS1P54), c-Rel (CREL), caudal type homeobox 1 (CDXA), DELTAEF1, cyclin E/E2F (E2F), E47, GATA3, GATA2, hepatocyte nuclear factor 3β (HNF3β), ikappa B kinase-like 2 (IK2), c-Myb (MYB), MYOD, cardiac-specific homeobox protein (NKX25), OCT1, P53, sex-determining region Y (SRY), STAT, TATA, and TST1 [32,33,34,35,36] (Table S1). The 5′-distal region of +55/+372 in the cGH contained a cluster of twenty TFBSs and highly conserved near-consensus TFBSs (score = 1.000) for the transcriptional factor, which was acute myeloid leukemia-1 (AML1).…”